1. Home
  2. CRVS vs CSR Comparison

CRVS vs CSR Comparison

Compare CRVS & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.89

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo D/B/A Centerspace

CSR

D/B/A Centerspace

HOLD

Current Price

$55.13

Market Cap

931.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
CSR
Founded
2014
1970
Country
United States
United States
Employees
N/A
349
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
931.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CRVS
CSR
Price
$14.89
$55.13
Analyst Decision
Strong Buy
Hold
Analyst Count
6
6
Target Price
$30.17
$69.80
AVG Volume (30 Days)
1.4M
164.2K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
4.58%
EPS Growth
48.04
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.24
Revenue Next Year
N/A
$2.72
P/E Ratio
N/A
$62.27
Revenue Growth
N/A
N/A
52 Week Low
$3.96
$52.76
52 Week High
$26.95
$69.61

Technical Indicators

Market Signals
Indicator
CRVS
CSR
Relative Strength Index (RSI) 57.88 34.56
Support Level $14.24 $54.50
Resistance Level $16.85 $58.13
Average True Range (ATR) 0.81 1.39
MACD 0.12 0.20
Stochastic Oscillator 60.08 13.04

Price Performance

Historical Comparison
CRVS
CSR

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About CSR D/B/A Centerspace

Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.

Share on Social Networks: